Potential disease-modifying therapy enters Phase 2

[PDWarrior1900]

"Following the review of the data of the 101 trial, the drug advanced to the Phase II 201 trial (NCT05424276). This is a 12-week, randomized, double-blind, multi-center, placebo-controlled, dose-ranging clinical trial of three IkT 148009 doses in patients with untreated Parkinson's disease."

------------------------------------

youtu.be/aQfvVEXgmfc(Not working as expected?)

[reedboat2]

pretty encouraging video presentation. Good thing to keep an eye on. Thanks, JG

[WinnieThePoo]

I thought that the trial had had to stop due to an fda hold notice

[PDWarrior1900 in reply to WinnieThePoo]

do you have a link for that? cause i can't find anything

[Hidden in reply to PDWarrior1900]

Take a look at my posts.

[WinnieThePoo]

prnewswire.com/news-release...

[PDWarrior1900]

thanks! and that's a real 'RED FLAG' isn't it? bummer

[Boscoejean]

Why doesn't the article tell you why the hold was placed? I looked up reasons for holds on clinical trials. The article discusses possible reasons a trial could be put on hold:

fda.gov/drugs/investigation...

[PDWarrior1900 in reply to Boscoejean]

good point! good research! good post!

[Boscoejean]

Inhibikase says that no adverse effects have been observed in past research so since they are supposed to supply a letter to the company within 30 days of the reason they have put the study on hold it seems like that should be available around Dec 7th

[Eva_mentoz]

Hello everyone FDA as stop the trial

fiercebiotech.com/biotech/i...

[PDWarrior1900]

good post, thanks!